Eddie Howe will be hoping and praying the injury to Alexander Isak isn't a severe one with the Carabao Cup Final on the horizon. Newcastle United were without their main man for the defeat to ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

They are irreplaceable. “To SAFC fans they are priceless and this would never be reflected in any insurance claim.” To Michael the museum is much more than a collection of memorabilia and a ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

It’ll be interesting to see how we approach this game – and the rest of the season really. Play offs are pretty much guaranteed but we will only have a chance of the automatic spots if we win ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

Be part of the run-in. Secure a six-game ticket pack to ensure you can catch the thrilling conclusion to our 24-25 season. The Lads remain unbeaten at home in the league this season, putting on some ...

Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret antigens that could form the backbone of off-the-shelf immunotherapies ...